A Single-Dose Study of Denosumab in Patients With Various Degrees of Renal Impairment

por Block, Geoffrey A, Bone, Henry G, Fang, Liang, Lee, Edward, Padhi, Desmond
Publicado 2012

Understanding the role of the cytoprotective transcription factor nuclear factor erythroid 2-related factor 2—lessons from evolution, the animal kingdom and rare progeroid syndrome...

por Stenvinkel, Peter, Meyer, Colin J, Block, Geoffrey A, Chertow, Glenn M, Shiels, Paul G
Publicado 2019

Patterns of Hemodialysis Catheter Dysfunction Defined According to National Kidney Foundation Guidelines As Blood Flow <300 mL/min

por Griffiths, Robert I., Newsome, Britt B., Block, Geoffrey A., Herbert, Robert J., Danese, Mark D.
Publicado 2011

Geographic variation of parathyroidectomy in patients receiving hemodialysis: a retrospective cohort analysis

por Wetmore, James B., Liu, Jiannong, Dluzniewski, Paul J., Ishani, Areef, Block, Geoffrey A., Collins, Allan J.
Publicado 2016

Safety and efficacy of ferric citrate in patients with nondialysis-dependent chronic kidney disease

por Chertow, Glenn M., Block, Geoffrey A., Neylan, John F., Pergola, Pablo E., Uhlig, Katrin, Fishbane, Steven
Publicado 2017

The effects of tenapanor on serum fibroblast growth factor 23 in patients receiving hemodialysis with hyperphosphatemia

por Block, Geoffrey A, Rosenbaum, David P, Yan, Andrew, Greasley, Peter J, Chertow, Glenn M, Wolf, Myles
Publicado 2019

An integrated analysis of safety and tolerability of etelcalcetide in patients receiving hemodialysis with secondary hyperparathyroidism

por Block, Geoffrey A., Chertow, Glenn M., Sullivan, John T., Deng, Hongjie, Mather, Omar, Tomlin, Holly, Serenko, Michael
Publicado 2019

Impact of Hemodialysis Catheter Dysfunction on Dialysis and Other Medical Services: An Observational Cohort Study

por Griffiths, Robert I., Newsome, Britt B., Leung, Grace, Block, Geoffrey A., Herbert, Robert J., Danese, Mark D.
Publicado 2012

Refining the definition of clinically important mineral and bone disorder in hemodialysis patients

por Danese, Mark D., Halperin, Marc, Lowe, Kimberly A., Bradbury, Brian D., Do, Thy P., Block, Geoffrey A.
Publicado 2015

Hemoglobin response to ferric citrate in patients with nondialysis‐dependent chronic kidney disease and iron deficiency anemia

por Pergola, Pablo E., Fishbane, Steven, LeWinter, Robin D., Neylan, John F., Uhlig, Katrin, Block, Geoffrey A., Chertow, Glenn M.
Publicado 2018

Etelcalcetide Is Effective at All Levels of Severity of Secondary Hyperparathyroidism in Hemodialysis Patients

por Cunningham, John, Block, Geoffrey A., Chertow, Glenn M., Cooper, Kerry, Evenepoel, Pieter, Iles, Jan, Sun, Yan, Ureña-Torres, Pablo, Bushinsky, David A.
Publicado 2019

Effect of ferric citrate on serum phosphate and fibroblast growth factor 23 among patients with nondialysis-dependent chronic kidney disease: path analyses

por Block, Geoffrey A, Pergola, Pablo E, Fishbane, Steven, Martins, Julian G, LeWinter, Robin D, Uhlig, Katrin, Neylan, John F, Chertow, Glenn M
Publicado 2019

Effects of etelcalcetide on fibroblast growth factor 23 in patients with secondary hyperparathyroidism receiving hemodialysis

por Wolf, Myles, Block, Geoffrey A, Chertow, Glenn M, Cooper, Kerry, Fouqueray, Bruno, Moe, Sharon M, Sun, Yan, Tomlin, Holly, Vervloet, Marc, Oberbauer, Rainer
Publicado 2019

Therapeutic Effect of Iron Citrate in Blocking Calcium Deposition in High Pi-Calcified VSMC: Role of Autophagy and Apoptosis

por Ciceri, Paola, Falleni, Monica, Tosi, Delfina, Martinelli, Carla, Cannizzo, Stefania, Marchetti, Giulia, D’Arminio Monforte, Antonella, Bulfamante, Gaetano, Block, Geoffrey A, Messa, Piergiorgio, Cozzolino, Mario
Publicado 2019

One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism

por Bushinsky, David A, Chertow, Glenn M, Cheng, Sunfa, Deng, Hongjie, Kopyt, Nelson, Martin, Kevin J, Rastogi, Anjay, Ureña-Torres, Pablo, Vervloet, Marc, Block, Geoffrey A
Publicado 2019

One-year safety and efficacy of intravenous etelcalcetide in patients on hemodialysis with secondary hyperparathyroidism

por Bushinsky, David A, Chertow, Glenn M, Cheng, Sunfa, Deng, Hongjie, Kopyt, Nelson, Martin, Kevin J, Rastogi, Anjay, Ureña-Torres, Pablo, Vervloet, Marc, Block, Geoffrey A
Publicado 2019

Use of Wastewater Metrics to Track COVID-19 in the US

por Varkila, Meri R. J., Montez-Rath, Maria E., Salomon, Joshua A., Yu, Xue, Block, Geoffrey A., Owens, Douglas K., Chertow, Glenn M., Parsonnet, Julie, Anand, Shuchi
Publicado 2023

Facility-level CKD-MBD composite score and risk of adverse clinical outcomes among patients on hemodialysis

por Block, Geoffrey A., Yusuf, Akeem A., Danese, Mark D., Wirtz, Heidi S., Hu, Yan, Do, Thy P., Cooper, Kerry, Gilbertson, David T., Bradbury, Brian D., Collins, Allan J.
Publicado 2016

Effects of vadadustat on hemoglobin concentrations in patients receiving hemodialysis previously treated with erythropoiesis-stimulating agents

por Haase, Volker H, Chertow, Glenn M, Block, Geoffrey A, Pergola, Pablo E, deGoma, Emil M, Khawaja, Zeeshan, Sharma, Amit, Maroni, Bradley J, McCullough, Peter A
Publicado 2019

Estimated SARS-CoV-2 Seroprevalence in US Patients Receiving Dialysis 1 Year After the Beginning of the COVID-19 Pandemic

por Anand, Shuchi, Montez-Rath, Maria, Han, Jialin, Cadden, LinaCel, Hunsader, Patti, Kerschmann, Russell, Beyer, Paul, Boyd, Scott D., Garcia, Pablo, Dittrich, Mary, Block, Geoffrey A., Parsonnet, Julie, Chertow, Glenn M.
Publicado 2021